Maximize Your R&D Investment in DHTs Through the Collection and Retention of Raw Sensor Data
Sensor-based digital health technologies (DHTs) have revolutionized the ability to remotely obtain and analyze clinically relevant information from clinical trial participants. Through ActiGraph’s 20 years of experience supporting clinical research, we’ve learned that a key factor of success when using DHTs for clinical investigation is the retention of high quality raw sensor data.
What You'll Learn
- Clarify myths surrounding the collection of raw sensor data
- Explain why objective raw data is essential to meaningful clinical insights
- Discuss how to maximize the long-term investment in clinical research